New Delhi: The Pune-based Serum Institute of India (SII) has ramped up manufacturing of COVID-19 vaccine and can present 10 crore doses of Covishield to the Centre by the following month and an additional 10 to 12 crore doses by July.
“We are pleased to inform that in June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country as compared to our production capacity of 6.5 crore doses in May,” the letter acknowledged.
The vaccine manufacturing firm claimed that its workers have been working round the clock to satisfy the rising demand for the vaccines in the nation, it wrote in letter to Union Home Minister Amit Shah.
India is presently utilizing made-in-India vaccines — Covishield manufactured by SII and Covaxin of Bharat Biotech — for its COVID-19 vaccination drive. The Russian Sputnik V has been authorized from the Drug Controller General of India (DCGI) for emergency use and is getting used in a couple of non-public hospitals.
Meanwhile, the Government of India targets to inoculate 1 crore folks every day, ANI quoted sources as saying.
According to the Union Health Ministry, a complete of 21,20,66,614 vaccine doses have been administered by means of 30,07,831 classes, as per the provisional report until 7 am right now. More than 30.35 Lakh (30,35,749) vaccine doses have been given in the final 24 hours.
(*10*)Source hyperlink
